Halozyme Therapeutics to acquire specialty pharma company Antares Pharma for $960m
Halozyme Therapeutics, a California-based publicly-listed biotech company, has agreed to acquire New Jersey-based specialty pharma company Antares Pharma for around $960 million with an objective to create a specialty product and drug delivery major. As per the terms of the deal, shareholders of the publicly-listed Antares Pharma will be paid $5.6 per share in cash. […]